ArticleMolecular genetics and metabolism
Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis.
Zackary M Herbst et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
cites it